Digital Payments Become Trending Payment Method for Global Merchants Operating in SEA, Ant International’s Antom Insights Show
6.9.2024 13:59:00 EEST | Business Wire | Press release
Digital payments have become the preferred payment method among shoppers in Southeast Asia when they purchase on global online platforms, Antom revealed today at the 2024 INCLUSION· Conference on the Bund, a global summit for technology and financial industry, in Shanghai.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240906284605/en/
Antom shared insights on global payment trends at the INCLUSION Conference, highlighting how payment innovations are helping merchants establish and grow in global markets. (From right to left: Jerry Li, Director of Global Strategic Partnerships, Antom, Ant International; Barbara Yu, Head of Product, Antom, Ant International; Eva Zhao, Marketing Director, POP MART International; Hang Wen, CTO, Xide International; and William Yang, Head of Growth, Antom, Ant International) (Photo: Business Wire)
From the perspective of payment preferences, local real-time methods such as DANA (Indonesia), Touch 'n Go eWallet (Malaysia), and TrueMoney (Thailand) dominate the SEA region, with Buy Now Pay Later (BNPL) also on the rise. In Europe and the Americas, card payments remain mainstream, though mobile payments are also growing rapidly, and BNPL and instalment plans are gaining popularity among young population, according to Antom, a leading merchant payment and digitization services provider under Ant international.
By leveraging AI technology and a wide-reaching network of payment channel partnerships, Antom has established local acquiring capabilities in over 40 countries globally, enabling businesses to integrate hundreds of payment methods and supports transactions in over 100 currencies. The company offers merchants tailored online and offline payment services, as well as digitization and digital marketing solutions, to support their global growth.
Chinese merchants going global is one of the most important customer bases that Antom serves. According to Antom, sectors such as e-commerce, online travel agents (OTAs), and transportation saw particularly strong growth in transaction volume, driven by the rapid development of standalone e-commerce websites and the robust recovery of the global travel market.
Southeast Asia is one of the most popular markets for Chinese businesses, with Malaysia, Indonesia, and Thailand being key markets. The region’s strategic location, booming digital economy, large young consumer base, and high mobile payment penetration rate are attracting an increasing number of Chinese enterprises.
“Chinese companies are entering a new phase of global expansion, placing greater emphasis on product innovation, localized operations, and brand building. Payments are a critical component in connecting merchants and consumers,” said Barbara Yu, Head of Product at Antom. “Take Southeast Asia as an example. In addition to offering a one-stop local acquiring solution across six countries in the region for merchants, Antom leverages its technology and extensive payment channel coverage to optimize every step of the transaction process, improving conversion rates and payment success rates, and maximizing the return on these companies’ marketing investments.”
Antom’s EasySafePay feature allows users to complete the entire payment process within the merchant’s App, enhancing the payment success rate and building consumer trust through a seamless payment experience. Antom Payment Orchestration, an all-in-one payment management Software as a Service (SaaS) platform, enables businesses to quickly connect with hundreds of payment methods globally, providing centralized, intelligent management of multiple payment channels, saving merchants roughly two-thirds of the time and technical resources. Additionally, Antom Co-pilot, an Artificial Intelligence (AI) assistant powered by Large Language Model (LLM), offers customized payment solutions and technical integration recommendations for merchants.
“Antom integrated multiple payment channels for us, reducing costs and allowing us to focus more on product development and operations. With Antom's support, we also improved channel management and enhanced payment stability,” said Hang Wen, CTO of Xide International, a global fashion brand expanding rapidly in the European and American markets.
He shared that the company focuses on developing clothing for 20 to 30-year-olds in Europe and North America. For customer acquisition, they target Instagram and live-streaming platforms, staying aligned with market trends. The brand also prioritizes localization, adjusting products, website design, and payment methods to fit the consumer habits of each market.
William Yang, Antom’s Head of Growth, introduced Antom’s digital services and growth tools, highlighting how businesses can quickly set up online stores in multiple digital wallets or Apps. The company also provides digital marketing solutions that drive user growth and improve payment conversion rates. It enables targeted customer engagement through tailor-made promotions, powered by privacy-preserving technology and partnerships with payment Apps.
"Digital payment innovations have inspired our international marketing strategies. Antom helped us implement targeted campaigns, attracting users more effectively and enhancing the customer experience,” said Shuai Zhao, Marketing Director of POP MART. “We expect its all-in-one digital marketing solutions to further boost traffic and improve operations."
POP MART is a leading toy brand operating in markets including Southeast Asia, East Asia, North America, Europe and Australia. By leveraging global artists and IP resources, it has built a diverse product line that attracts users worldwide. Fan engagement is a core strategy in POP MART's business development.
“The integration of trade and technology plays a pivotal role in shaping the global economy. At Ant International, we are committed to using innovative technologies to accelerate the digital transformation of commerce. Antom's goal is to empower global businesses with advanced payment solutions and digitization services, fostering sustainable growth in an increasingly interconnected marketplace,” said Leiming Chen, Chief Sustainability Officer of Ant International.
###
About Antom
Ant International’s Antom is a leading provider of payment and digitization services to merchants worldwide. Antom provides one-stop, vertical-specific digital payment solutions to meet the payment needs for merchants of all sizes, especially SMEs. With a presence in over 150 markets, Antom currently supports merchants in over 40 markets with the flexibility to accept payments in more than 100 currencies. Antom also provides digital marketing solutions and merchant digitization services to help merchant in digital operations and to better engage with their customers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240906284605/en/
Contacts
Press
Ant International
Janice Chen
janicechen.cyh@antgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom